US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pyxis Oncology, Inc.

1.26

+0.160014.55%

Post-market: 1.260.00000.00%19:47 EDT

Volume:1.29M

Turnover:1.60M

Market Cap:77.60M

PE:-0.95

High:1.33

Open:1.10

Low:1.10

Close:1.10

Loading ...

Overview Company News Filings

William Blair Sticks to Their Hold Rating for Pyxis Oncology (PYXS)

Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC

Top Cancer Stocks to Buy to Boost Your Portfolio's Health

Pyxis Oncology to Present Preclinical Data for Micvo Cancer Drug Candidate

MT Newswires Live

Pyxis Oncology Highlights Strategic Focus on Lead Candidate

Promising Prospects for Pyxis Oncology: Buy Rating Affirmed on Strong Clinical Profile and Strategic Focus

Promising Clinical Developments and Strategic Focus Drive Buy Rating for Pyxis Oncology

Pyxis Oncology Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

U.S. RESEARCH ROUNDUP-AT&T, Brighthouse Financial, ETSY

Pyxis Oncology Advances Cancer Therapeutics with MICVO

Pyxis Oncology Inc : Jefferies Cuts Target Price to $6 From $12

THOMSON REUTERS

Pyxis Oncology (PYXS) Gets a Hold from William Blair

Pyxis Oncology FY Net Income USD -77.331 Million

Pyxis Oncology FY Basic EPS USD -1.32

THOMSON REUTERS

Press Release: Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Pyxis Oncology Inc expected to post a loss of 33 cents a share - Earnings Preview

Pyxis Oncology to Participate at the Leerink Partners Global Healthcare Conference

Pyxis Oncology granted Fast Track designation for PYX-201 monotherapy

Pyxis Oncology Granted FDA Fast Track Designation for Pyx-201 Monotherapy in Patients With Recurrent or Metastatic Head and Neck Cancer

THOMSON REUTERS

Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PYXS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PYXS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PYXS\",,,,,undefined,":{"symbol":"PYXS","market":"US","secType":"STK","nameCN":"Pyxis Oncology, Inc.","latestPrice":1.26,"timestamp":1746216000000,"preClose":1.1,"halted":0,"volume":1292440,"hourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.26,"latestTime":"19:47 EDT","volume":3390,"amount":4296.056,"timestamp":1746229674554},"delay":0,"floatShares":44339648,"shares":61590415,"eps":-1.323124,"marketStatus":"Not Yet Opened","change":0.16,"latestTime":"05-02 16:00:00 EDT","open":1.1,"high":1.33,"low":1.1,"amount":1600555.6280959998,"amplitude":0.209091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.323124,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":0,"adr":0,"listingDate":1633665600000,"exchange":"NASDAQ","adjPreClose":1.1,"preHourTrading":{"tag":"盘前","latestPrice":1.1,"preClose":1.1,"latestTime":"09:29 EDT","volume":2,"amount":2.2,"timestamp":1746192599908},"postHourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.26,"latestTime":"19:47 EDT","volume":3390,"amount":4296.056,"timestamp":1746229674554},"volumeRatio":3.9046525666782124,"impliedVol":0.1049,"impliedVolPercentile":0.072},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PYXS\",,,,,undefined,":{"symbol":"PYXS","floatShares":44339648,"roa":"-24.77%","roe":"-62.75%","lyrEps":-1.323124,"volumeRatio":3.9046525666782124,"shares":61590415,"dividePrice":0,"high":1.33,"amplitude":0.209091,"preClose":1.1,"low":1.1,"week52Low":0.8332,"pbRate":"0.64","psRate":"4.81","week52High":5.3899,"institutionHeld":0,"latestPrice":1.26,"eps":-1.323124,"divideRate":0,"volume":1292440,"delay":0,"ttmEps":-1.323124,"open":1.1,"prevYearClose":1.56,"prevWeekClose":1.06,"prevMonthClose":1.1,"prevQuarterClose":0.9799,"fiveDayClose":1.06,"twentyDayClose":0.9355,"sixtyDayClose":1.51},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PYXS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530239189","title":"William Blair Sticks to Their Hold Rating for Pyxis Oncology (PYXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530239189","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530239189?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:25","pubTimestamp":1745853911,"startTime":"0","endTime":"0","summary":"In a report released today, Andy Hsieh from William Blair maintained a Hold rating on Pyxis Oncology (PYXS – Research Report). The company’s shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-hold-rating-for-pyxis-oncology-pyxs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-hold-rating-for-pyxis-oncology-pyxs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS"],"gpt_icon":0},{"id":"2530168669","title":"Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2530168669","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530168669?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:17","pubTimestamp":1745601420,"startTime":"0","endTime":"0","summary":"Gene signatures associated with increased efficacy of micvotabart pelidotin  due to greater linker cleavage were identified based on differential gene expression analysis of PDX responders/non-responders. Mouse analog of MICVO in a syngeneic model indicated strong activity of the cytotoxic Auristatin0101 payload and potential for MICVO monotherapy to drive immunogenic cell death, a key hypothesis for MICVO’s mechanism. Combination of a mouse analog of MICVO and anti-PD-1 therapy in a syngeneic model resulted in enhanced tumor clearance and longer immunological memory compared to either treatment alone. Totality of pre-clinical data presented at AACR 2025 strongly support MICVO’s unique, three-pronged mechanism of action of driving anti-tumor activity via direct tumor killing, bystander effect and immunogenic cell death, further reinforcing the potential patient benefit for MICVO as a monotherapy and in combination with an anti-PD-1 therapy. Key findings from preclinical studies of MICV","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pyxis-oncology-presents-promising-preclinical-171700556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0965509283.SGD","IE000M9KFDE8.USD","BK4533","LU2112291526.USD","LU1941712264.USD","BK4007","IE00BBT3K403.USD","LU0985320562.USD","LU0238689110.USD","LU1585245621.USD","PACI.U","LU1941712348.USD","LU0266013472.USD","MRK","LU0070302665.USD","LU1066051225.USD","BK4550","ADC","LU2023250843.SGD","IE00B4R5TH58.HKD","LU1069347547.HKD","IE00BJT1NW94.SGD","SG9999002224.SGD","LU0203345920.USD","LU0211331839.USD","LU0965509010.AUD","IE00B1BXHZ80.USD","LU0965509101.SGD","IE00BLSP4239.USD","LU2089984988.USD","IE00B2B36J28.USD","IE0009355771.USD","LU2361044949.HKD","LU1291159041.SGD","LU0106261372.USD","LU2361045086.USD","LU0058720904.USD","LU2324357040.USD","PYXS","BK4559","L","LU0861579265.USD","LU1116320901.HKD","LU1430594728.SGD","SG9999014575.USD","LU2361044865.SGD","SG9999001176.USD","SG9999014542.SGD","LU0006306889.USD","LU0320765646.SGD"],"gpt_icon":0},{"id":"2527225559","title":"Top Cancer Stocks to Buy to Boost Your Portfolio's Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2527225559","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527225559?lang=en_us&edition=fundamental","pubTime":"2025-04-16 21:45","pubTimestamp":1744811100,"startTime":"0","endTime":"0","summary":"An updated edition of the March 7, 2025, article.The cancer market is seeing significant growth and evolution as there is a rising demand for targeted, less toxic cancer medicines. According to the American Cancer Society, 2024 was the first time that new cancer cases in the United States were expected to cross the 2-million mark. This resulted in a massive increase in the global spending on cancer medicines.Verastem Oncology’s new drug application  seeking approval of its novel combination regimen of avutometinib plus defactinib for treating KRAS mutant recurrent low-grade serous ovarian cancer , a rare and distinct type of ovarian cancer, is under priority review with the FDA. The FDA’s decision on the NDA is expected on June 30, 2025. Avutometinib is an RAF/M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-cancer-stocks-buy-boost-134500112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0456855351.SGD","LU0029864427.USD","LU1066051498.USD","RLAY","MBC","AZN","LU0203347892.USD","LU2417539215.USD","LU0795875086.SGD","IE00BFTCPJ56.SGD","LU0949170772.SGD","LU1839511570.USD","BK4599","LU1496350171.SGD","LU1057294990.SGD","LU1894683264.USD","LU2237443622.USD","SGXZ57979304.SGD","LU2089984988.USD","IE00BVYPNW00.USD","ABBV","LU0795875169.SGD","LU0820561818.USD","BK4534","BK4588","LU1496350502.SGD","LU0306806265.USD","LU2237443465.HKD","PYXS","L","LU2462157665.USD","LU0203345920.USD","LU0868494617.USD","VSTM","BK4550","LU1934455863.HKD","LU0320765992.SGD","LU0321505439.SGD","IE00BJT1NW94.SGD","LU0912757837.SGD","LU0234570918.USD","LU1244550221.USD","LU0310800379.SGD","LU1023059063.AUD","BK4107","NVS","SG9999002232.USD","LU1093756168.USD","LU1003077747.HKD"],"gpt_icon":1},{"id":"2522836901","title":"Pyxis Oncology to Present Preclinical Data for Micvo Cancer Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522836901","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522836901?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:38","pubTimestamp":1742938727,"startTime":"0","endTime":"0","summary":"Pyxis Oncology  said Tuesday it will present new preclinical data from its phase 1 study of micvotabart pelidotin, antibody-drug conjugate to treat recurrent and metastatic head and neck squamous cell carcinoma, at the American Association for Cancer Research Meeting in Chicago in April.In phase 1 trial, the drug showed monotherapy effect on multiple tumor types with significant tumor regression, according to the company. It has begun the part 2 monotherapy expansion cohorts of the ongoing Phase 1 to assess Micvo in second-line and third-line recurrent and metastatic head and neck squamous cell carcinoma patients who have received prior platinum and PD-1 inhibitor therapy and those who received prior EGFRi and PD-1 inhibitor therapy.The company added that preliminary data for patients who received prior platinum and PD-1 inhibitor therapy are expected in H2. Preliminary data from those who received prior EGFRi and PD-1 inhibitor therapy are expected in H1 2026.The company said it also ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2361044949.HKD","LU0265550946.USD","BK4007","IE00BSNM7G36.USD","LU1917777945.USD","LU1989771016.USD","IE00BBT3K403.USD","LU2461242641.AUD","LU1699723380.USD","LU1585245621.USD","IE00BFTCPJ56.SGD","LU1974910355.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4588","SG9999014575.USD","LU1983299246.USD","PYXS","BK4550","LU1037948897.HKD","MRK","SG9999002224.SGD","SG9999014559.SGD","LU1291159041.SGD","BK4516","LU1929549753.HKD","LU1037948541.HKD","LU2023250504.SGD","LU1934455863.HKD","IE000M9KFDE8.USD","LU1116320901.HKD","LU1066051811.HKD","LU0211331839.USD","LU1066051498.USD","SG9999015358.SGD","IE00BN8TJ469.HKD","LU0208291251.USD","LU0320765489.SGD","LU0070302665.USD","LU1066053197.SGD","IE0002141913.USD","LU0266013472.USD","SGXZ57979304.SGD","LU0203345920.USD","LU2106854487.HKD","LU1941712264.USD","SG9999001176.USD","LU0965509010.AUD","LU1035773651.USD","LU1093756325.SGD"],"gpt_icon":0},{"id":"2521747557","title":"Pyxis Oncology Highlights Strategic Focus on Lead Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2521747557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521747557?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:57","pubTimestamp":1742817443,"startTime":"0","endTime":"0","summary":"Pyxis Oncology ( ($PYXS) ) has issued an update. On March 24, 2025, Pyxis Oncology updated its corporate presentation, highlighting its focus on ad...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyxis-oncology-highlights-strategic-focus-on-lead-candidate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyxis-oncology-highlights-strategic-focus-on-lead-candidate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2520186904","title":"Promising Prospects for Pyxis Oncology: Buy Rating Affirmed on Strong Clinical Profile and Strategic Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2520186904","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520186904?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:15","pubTimestamp":1742386543,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Sean Lee from Citi maintained a Buy rating on Pyxis Oncology (PYXS – Research Report), with a price target of $5.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-prospects-for-pyxis-oncology-buy-rating-affirmed-on-strong-clinical-profile-and-strategic-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-prospects-for-pyxis-oncology-buy-rating-affirmed-on-strong-clinical-profile-and-strategic-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS"],"gpt_icon":0},{"id":"2520183208","title":"Promising Clinical Developments and Strategic Focus Drive Buy Rating for Pyxis Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2520183208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520183208?lang=en_us&edition=fundamental","pubTime":"2025-03-19 19:45","pubTimestamp":1742384741,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky has maintained their bullish stance on PYXS stock, giving a Buy rating yesterday. Sam Slutsky has given his Buy...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-clinical-developments-and-strategic-focus-drive-buy-rating-for-pyxis-oncology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-clinical-developments-and-strategic-focus-drive-buy-rating-for-pyxis-oncology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS"],"gpt_icon":0},{"id":"2520906503","title":"Pyxis Oncology Price Target Maintained With a $5.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520906503","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520906503?lang=en_us&edition=fundamental","pubTime":"2025-03-19 18:48","pubTimestamp":1742381280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PYXS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2025 06:48 ET (10:48 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS"],"gpt_icon":0},{"id":"2520294796","title":"U.S. RESEARCH ROUNDUP-AT&T, Brighthouse Financial, ETSY","url":"https://stock-news.laohu8.com/highlight/detail?id=2520294796","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520294796?lang=en_us&edition=fundamental","pubTime":"2025-03-19 15:35","pubTimestamp":1742369743,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-AT&T, Brighthouse Financial, ETSY March 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AT&T, B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nL4N3Q20KN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0342679015.USD","LU0198837287.USD","LU2095319765.USD","LU0354030511.USD","LU0965509283.SGD","LU1633808545.USD","ETSY","LU0158827948.USD","LU0081259029.USD","LU1778281490.HKD","IE00BFXG1179.USD","T","LU0289961442.SGD","LU0861579265.USD","LU1712237335.SGD","LU1803068979.SGD","BK4554","BK4082","LU0472753341.HKD","LU0557290698.USD","LU2384288077.EUR","KRRO","IE00B5TLWC47.USD","LU1267930730.SGD","BK4550","FERG","BK4507","RRC","BK4534","LU2458330169.SGD","BK4567","BK4023","LU2125910336.SGD","BK4585","TNDM","PYXS","LU1923621640.USD","BHF","BK4122","LU2236285917.USD","LU0672654240.SGD","LU2125154778.USD","PTMN","LU0109391861.USD","LU2065170008.USD","BK4220","LU2360032135.SGD","CMG","BK4515"],"gpt_icon":1},{"id":"2520699006","title":"Pyxis Oncology Advances Cancer Therapeutics with MICVO","url":"https://stock-news.laohu8.com/highlight/detail?id=2520699006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520699006?lang=en_us&edition=fundamental","pubTime":"2025-03-19 11:55","pubTimestamp":1742356506,"startTime":"0","endTime":"0","summary":"Pyxis Oncology, Inc. ( ($PYXS) ) has released its Q4 earnings. Here is a breakdown of the information Pyxis Oncology, Inc. presented to its investo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyxis-oncology-advances-cancer-therapeutics-with-micvo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyxis-oncology-advances-cancer-therapeutics-with-micvo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","PYXS"],"gpt_icon":0},{"id":"2520099742","title":"Pyxis Oncology Inc : Jefferies Cuts Target Price to $6 From $12","url":"https://stock-news.laohu8.com/highlight/detail?id=2520099742","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520099742?lang=en_us&edition=fundamental","pubTime":"2025-03-19 11:54","pubTimestamp":1742356484,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q1154:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2520985498","title":"Pyxis Oncology (PYXS) Gets a Hold from William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2520985498","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520985498?lang=en_us&edition=fundamental","pubTime":"2025-03-19 00:25","pubTimestamp":1742315110,"startTime":"0","endTime":"0","summary":"In a report released today, Andy Hsieh from William Blair reiterated a Hold rating on Pyxis Oncology (PYXS – Research Report). The company’s shares...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pyxis-oncology-pyxs-gets-a-hold-from-william-blair?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pyxis-oncology-pyxs-gets-a-hold-from-william-blair?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PYXS"],"gpt_icon":0},{"id":"2520242956","title":"Pyxis Oncology FY Net Income USD -77.331 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2520242956","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520242956?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:47","pubTimestamp":1742298456,"startTime":"0","endTime":"0","summary":"Mar 18 (Reuters) - Pyxis Oncology FY income from operations USD -89.46 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 18-MAR-202510:44:33.797 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nRSDb1QD9p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2520230629","title":"Pyxis Oncology FY Basic EPS USD -1.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2520230629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520230629?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:30","pubTimestamp":1742297400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nPLXD473B9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2520621313","title":"Press Release: Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2520621313","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520621313?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:30","pubTimestamp":1742297400,"startTime":"0","endTime":"0","summary":"- Recently reported positive preliminary data from Phase 1 dose escalation trial of micvotabart pelidotin , including a confirmed 50% objective response rate by RECIST 1.1 in recurrent and metastatic head and neck squamous cell carcinoma . - Received Fast Track Designation from the U.S. Food and Drug Administration for MICVO for the treatment of adult patients with R/M HNSCC whose disease has progressed following treatment with platinum-based chemotherapy and an anti-PD-1 therapy. - Initiated monotherapy expansion cohorts of MICVO for 2L and 3L R/M HNSCC patients who have received prior platinum-based chemotherapy and prior PD-1 inhibitor therapy with preliminary data expected in 2H25 and 2/3L R/M HNSCC patients who have received prior EGFRi and PD-1 inhibitor therapy with preliminary data expected 1H26","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","LU2089984988.USD","BK4516","LU1941712264.USD","SG9999002232.USD","BK4080","LU2112291526.USD","SG9999002224.SGD","LU0006306889.USD","LU2023250843.SGD","BK4007","BK4550","IE00BBT3K403.USD","LU1585245621.USD","LU2324357040.USD","ORR","IE00B2B36J28.USD","LU1066051225.USD","R","LU2361044949.HKD","SG9999001176.USD","LU0238689110.USD","LU1430594728.SGD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU1934455194.USD","SG9999015358.SGD","LU2361044865.SGD","MRK","SG9999015341.SGD","IE00BJT1NW94.SGD","ADC","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1066051811.HKD","LU1934455863.HKD","IE000M9KFDE8.USD","L","LU0203345920.USD","LU0070302665.USD","LU2461242641.AUD","LU1917777945.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","PYXS","LU1699723380.USD","LU1057294990.SGD","LU1983299246.USD","LU0053666078.USD","LU2106854487.HKD"],"gpt_icon":0},{"id":"2520752582","title":"Pyxis Oncology Inc  expected to post a loss of 33 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2520752582","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520752582?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:40","pubTimestamp":1742215220,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Inc  expected to post a loss of33cents a share - Earnings Preview Pyxis Oncology Inc PYXS.OQ PYXS.O is expected to show no change in quarterly revenue when it reports  results on March ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nL8N3Q00XV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS"],"gpt_icon":0},{"id":"2516463855","title":"Pyxis Oncology to Participate at the Leerink Partners Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516463855","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516463855?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:30","pubTimestamp":1741005000,"startTime":"0","endTime":"0","summary":"BOSTON, March  03, 2025  (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035521/0/en/Pyxis-Oncology-to-Participate-at-the-Leerink-Partners-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS","BK4080","BK4231","BK4137","HCSG","ADC","BK4139"],"gpt_icon":0},{"id":"2514783476","title":"Pyxis Oncology granted Fast Track designation for PYX-201 monotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2514783476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514783476?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:35","pubTimestamp":1740573315,"startTime":"0","endTime":"0","summary":"Pyxis Oncology (PYXS) announced that the U.S. Food and Drug Administration has granted Fast Track Designation to PYX-201 for the treatment of adult...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pyxis-oncology-granted-fast-track-designation-for-pyx-201-monotherapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pyxis-oncology-granted-fast-track-designation-for-pyx-201-monotherapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B5TLWC47.USD","IE00BFXG0V08.USD","BK4104","PYXS","IE00BYQQ9H92.USD","BK4588","BK4567","BK4139","BK4585","FAST"],"gpt_icon":0},{"id":"2514083176","title":"Pyxis Oncology Granted FDA Fast Track Designation for Pyx-201 Monotherapy in Patients With Recurrent or Metastatic Head and Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2514083176","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514083176?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:30","pubTimestamp":1740573000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nTUA3LT8KW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PYXS"],"gpt_icon":0},{"id":"2514680834","title":"Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2514680834","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514680834?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:30","pubTimestamp":1740573000,"startTime":"0","endTime":"0","summary":"Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) whose disease has progressed following treatment with platinum-bas","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3032809/0/en/Pyxis-Oncology-Granted-FDA-Fast-Track-Designation-for-PYX-201-Monotherapy-in-Patients-with-Recurrent-or-Metastatic-Head-and-Neck-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0265550946.USD","BK4139","BK4231","LU1989772923.USD","L","LU1291159041.SGD","SG9999001176.USD","BK4107","LU1989772840.SGD","ADC","IE00BBT3K403.USD","IE00BYQQ9H92.USD","LU1934455863.HKD","SG9999014559.SGD","IE0002141913.USD","FAST","IE00B4R5TH58.HKD","LU0985320562.USD","SG9999014567.USD","LU0211331839.USD","LU1066053197.SGD","LU1069347547.HKD","LU1066051225.USD","PYXS","LU0203345920.USD","LU1941712264.USD","LU0006306889.USD","LU2468319806.SGD","IE00BLSP4452.SGD","LU2089984988.USD","SG9999014542.SGD","LU1917777945.USD","SG9999015341.SGD","LU1066051498.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU1061106388.HKD","LU1023059063.AUD","LU1430594728.SGD","LU0320765646.SGD","BK4567","LU1699723380.USD","LU2106854487.HKD","BK4534","LU0106261372.USD","IE00B2B36J28.USD","LU2112291526.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":66,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PYXS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-18","symbol":"PYXS","fiscalQuarterEnding":"2024/12","expectedEps":-0.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2024-11-12","symbol":"PYXS","fiscalQuarterEnding":"2024/09","expectedEps":-0.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2024-08-14","symbol":"PYXS","fiscalQuarterEnding":"2024/06","expectedEps":-0.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2024-05-14","symbol":"PYXS","fiscalQuarterEnding":"2024/03","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2024-03-21","symbol":"PYXS","fiscalQuarterEnding":"2023/12","expectedEps":-0.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710993600000,"reportTimeType":"pre","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PYXS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PYXS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.4286,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":7,"updateTime":1732248000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PYXS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PYXS","date":"2025-05-02","current":-0.876097,"percent":0.686567,"low":-8.295353,"twenty":-3.602943,"median":-1.135315,"eighty":-0.77056,"high":-0.361135,"avg":-2.045933,"sd":1.737855,"marketCap":67749456},"quantilePoints":[{"date":"2021-10-08","current":-8.027761,"twenty":-7.000853,"median":-5.460491,"eighty":-3.942431,"marketCap":423392125},{"date":"2021-10-15","current":-7.158087,"twenty":-7.278503,"median":-7.179372,"eighty":-6.139529,"marketCap":377524644},{"date":"2021-10-22","current":-7.924373,"twenty":-7.797875,"median":-7.194576,"eighty":-7.01456,"marketCap":417939347},{"date":"2021-10-29","current":-8.112904,"twenty":-7.957214,"median":-7.453046,"eighty":-7.096054,"marketCap":427882647},{"date":"2021-11-05","current":-7.346617,"twenty":-8.064251,"median":-7.83923,"eighty":-7.160519,"marketCap":387467944},{"date":"2021-11-12","current":-7.188495,"twenty":-8.027761,"median":-7.453046,"eighty":-7.150789,"marketCap":379128403},{"date":"2021-11-19","current":-6.530285,"twenty":-8.0083,"median":-7.297964,"eighty":-6.572742,"marketCap":416142385},{"date":"2021-11-26","current":-6.489849,"twenty":-7.968161,"median":-7.194576,"eighty":-6.360457,"marketCap":413565652},{"date":"2021-12-03","current":-6.161313,"twenty":-7.92194,"median":-7.161128,"eighty":-6.269642,"marketCap":392629696},{"date":"2021-12-10","current":-4.599504,"twenty":-7.909777,"median":-7.054699,"eighty":-6.108748,"marketCap":293103383},{"date":"2021-12-17","current":-4.29624,"twenty":-7.887883,"median":-6.583356,"eighty":-5.099226,"marketCap":273777885},{"date":"2021-12-23","current":-4.958366,"twenty":-7.83923,"median":-6.472159,"eighty":-4.735973,"marketCap":315971889},{"date":"2021-12-31","current":-5.544677,"twenty":-7.608128,"median":-6.388761,"eighty":-4.857278,"marketCap":353334518},{"date":"2022-01-07","current":-5.104944,"twenty":-7.510822,"median":-6.288084,"eighty":-4.857278,"marketCap":325312546},{"date":"2022-01-14","current":-5.206032,"twenty":-7.39527,"median":-6.161313,"eighty":-4.872441,"marketCap":331754378},{"date":"2022-01-21","current":-4.811789,"twenty":-7.356348,"median":-6.100661,"eighty":-4.857278,"marketCap":306631231},{"date":"2022-01-28","current":-4.25075,"twenty":-7.307695,"median":-5.81256,"eighty":-4.84818,"marketCap":270879060},{"date":"2022-02-04","current":-4.321512,"twenty":-7.259042,"median":-5.504241,"eighty":-4.792582,"marketCap":275388343},{"date":"2022-02-11","current":-3.811017,"twenty":-7.205523,"median":-5.368642,"eighty":-4.623765,"marketCap":242857089},{"date":"2022-02-18","current":-3.654331,"twenty":-7.189711,"median":-5.206032,"eighty":-4.399349,"marketCap":232872248},{"date":"2022-02-25","current":-3.159,"twenty":-7.173899,"median":-5.104944,"eighty":-4.333642,"marketCap":201307268},{"date":"2022-03-04","current":-2.22899,"twenty":-7.160519,"median":-5.074618,"eighty":-4.262881,"marketCap":142042408},{"date":"2022-03-11","current":-2.330078,"twenty":-7.150789,"median":-5.00891,"eighty":-4.128434,"marketCap":148484241},{"date":"2022-03-18","current":-2.754648,"twenty":-7.091189,"median":-4.948257,"eighty":-3.780691,"marketCap":175539938},{"date":"2022-03-25","current":-2.375568,"twenty":-7.01456,"median":-4.892659,"eighty":-3.269185,"marketCap":151383066},{"date":"2022-04-01","current":-1.514143,"twenty":-6.776977,"median":-4.864859,"eighty":-2.912659,"marketCap":115037013},{"date":"2022-04-08","current":-1.594728,"twenty":-6.572742,"median":-4.821897,"eighty":-2.615147,"marketCap":121159431},{"date":"2022-04-14","current":-1.548073,"twenty":-6.514111,"median":-4.811789,"eighty":-2.474634,"marketCap":117614873},{"date":"2022-04-22","current":-1.246941,"twenty":-6.475697,"median":-4.756191,"eighty":-2.394775,"marketCap":94736363},{"date":"2022-04-29","current":-1.038157,"twenty":-6.428186,"median":-4.62983,"eighty":-2.330078,"marketCap":78873989},{"date":"2022-05-06","current":-0.961884,"twenty":-6.388761,"median":-4.480726,"eighty":-2.254263,"marketCap":73079165},{"date":"2022-05-13","current":-0.86541,"twenty":-6.374609,"median":-4.387219,"eighty":-1.911128,"marketCap":61037378},{"date":"2022-05-20","current":-0.951094,"twenty":-6.339557,"median":-4.33162,"eighty":-1.594728,"marketCap":67080683},{"date":"2022-05-27","current":-1.066768,"twenty":-6.294231,"median":-4.29624,"eighty":-1.532805,"marketCap":75239144},{"date":"2022-06-03","current":-1.0582,"twenty":-6.247238,"median":-4.25075,"eighty":-1.347884,"marketCap":74634814},{"date":"2022-06-10","current":-1.02821,"twenty":-6.197705,"median":-4.190098,"eighty":-1.189259,"marketCap":72519657},{"date":"2022-06-17","current":-1.015357,"twenty":-6.15727,"median":-4.04352,"eighty":-1.12564,"marketCap":71613161},{"date":"2022-06-24","current":-1.002505,"twenty":-6.141096,"median":-3.811017,"eighty":-1.072056,"marketCap":70706666},{"date":"2022-07-01","current":-1.045347,"twenty":-6.100661,"median":-3.677076,"eighty":-1.066768,"marketCap":73728318},{"date":"2022-07-08","current":-1.182442,"twenty":-6.096617,"median":-3.260088,"eighty":-1.066768,"marketCap":83397606},{"date":"2022-07-15","current":-1.27241,"twenty":-5.897474,"median":-3.073075,"eighty":-1.066768,"marketCap":89743076},{"date":"2022-07-22","current":-1.203863,"twenty":-5.791331,"median":-2.820355,"eighty":-1.066768,"marketCap":84908432},{"date":"2022-07-29","current":-1.135315,"twenty":-5.591177,"median":-2.643451,"eighty":-1.070195,"marketCap":80073788},{"date":"2022-08-05","current":-1.195294,"twenty":-5.512328,"median":-2.506983,"eighty":-1.071052,"marketCap":84304101},{"date":"2022-08-12","current":-1.250989,"twenty":-5.504241,"median":-2.451384,"eighty":-1.071855,"marketCap":88232250},{"date":"2022-08-19","current":-1.008852,"twenty":-5.469241,"median":-2.395786,"eighty":-1.066768,"marketCap":88724535},{"date":"2022-08-26","current":-0.940916,"twenty":-5.313533,"median":-2.360405,"eighty":-1.061627,"marketCap":82749819},{"date":"2022-09-02","current":-0.930726,"twenty":-5.276793,"median":-2.314915,"eighty":-1.048774,"marketCap":81853611},{"date":"2022-09-09","current":-0.913742,"twenty":-5.234336,"median":-2.292171,"eighty":-1.039901,"marketCap":80359932},{"date":"2022-09-16","current":-0.750695,"twenty":-5.145379,"median":-2.22899,"eighty":-1.023926,"marketCap":66020614},{"date":"2022-09-23","current":-0.655584,"twenty":-5.104944,"median":-1.912825,"eighty":-1.019402,"marketCap":57656011},{"date":"2022-09-30","current":-0.669171,"twenty":-5.092813,"median":-1.713484,"eighty":-1.014114,"marketCap":58850954},{"date":"2022-10-07","current":-0.65041,"twenty":-5.081694,"median":-1.594728,"eighty":-1.005075,"marketCap":57200979},{"date":"2022-10-14","current":-0.617524,"twenty":-5.073607,"median":-1.548073,"eighty":-0.983479,"marketCap":54308795},{"date":"2022-10-21","current":-0.61387,"twenty":-5.069563,"median":-1.480212,"eighty":-0.968263,"marketCap":53987441},{"date":"2022-10-28","current":-0.68695,"twenty":-5.033171,"median":-1.314802,"eighty":-0.940828,"marketCap":60414518},{"date":"2022-11-04","current":-0.484681,"twenty":-4.978584,"median":-1.27452,"eighty":-0.92665,"marketCap":49168502},{"date":"2022-11-11","current":-0.47201,"twenty":-4.952301,"median":-1.27241,"eighty":-0.914661,"marketCap":47883051},{"date":"2022-11-18","current":-0.443499,"twenty":-4.948257,"median":-1.248965,"eighty":-0.896339,"marketCap":44990786},{"date":"2022-11-25","current":-0.481514,"twenty":-4.926018,"median":-1.240279,"eighty":-0.882491,"marketCap":48847139},{"date":"2022-12-02","current":-0.438748,"twenty":-4.892659,"median":-1.220999,"eighty":-0.86541,"marketCap":44508742},{"date":"2022-12-09","current":-0.392814,"twenty":-4.884572,"median":-1.212431,"eighty":-0.769717,"marketCap":39848982},{"date":"2022-12-16","current":-0.367471,"twenty":-4.872441,"median":-1.195294,"eighty":-0.689873,"marketCap":37278080},{"date":"2022-12-23","current":-0.405485,"twenty":-4.866376,"median":-1.17864,"eighty":-0.672428,"marketCap":41134433},{"date":"2022-12-30","current":-0.424492,"twenty":-4.857278,"median":-1.172214,"eighty":-0.663737,"marketCap":43062609},{"date":"2023-01-06","current":-0.459339,"twenty":-4.857278,"median":-1.165305,"eighty":-0.655584,"marketCap":46597600},{"date":"2023-01-13","current":-0.484681,"twenty":-4.821897,"median":-1.161021,"eighty":-0.65041,"marketCap":49168502},{"date":"2023-01-20","current":-0.503688,"twenty":-4.817854,"median":-1.148168,"eighty":-0.637308,"marketCap":51096678},{"date":"2023-01-27","current":-0.503688,"twenty":-4.8128,"median":-1.133871,"eighty":-0.620447,"marketCap":51096678},{"date":"2023-02-03","current":-0.510024,"twenty":-4.807745,"median":-1.10961,"eighty":-0.601446,"marketCap":51739404},{"date":"2023-02-10","current":-0.478346,"twenty":-4.782473,"median":-1.075336,"eighty":-0.518894,"marketCap":48525776},{"date":"2023-02-17","current":-0.535367,"twenty":-4.74406,"median":-1.071052,"eighty":-0.515093,"marketCap":54310306},{"date":"2023-02-24","current":-0.715935,"twenty":-4.699581,"median":-1.066768,"eighty":-0.51636,"marketCap":72627983},{"date":"2023-03-03","current":-0.719102,"twenty":-4.648026,"median":-1.066768,"eighty":-0.518261,"marketCap":72949346},{"date":"2023-03-10","current":-0.56071,"twenty":-4.611634,"median":-1.062484,"eighty":-0.521429,"marketCap":56881208},{"date":"2023-03-17","current":-0.874327,"twenty":-4.569178,"median":-1.053916,"eighty":-0.530299,"marketCap":88696121},{"date":"2023-03-24","current":-0.621811,"twenty":-4.467079,"median":-1.045347,"eighty":-0.535367,"marketCap":75063167},{"date":"2023-03-31","current":-1.128264,"twenty":-4.406426,"median":-1.049631,"eighty":-0.539965,"marketCap":136200588},{"date":"2023-04-06","current":-1.0326,"twenty":-4.396317,"median":-1.049631,"eighty":-0.550102,"marketCap":124652408},{"date":"2023-04-14","current":-0.996023,"twenty":-4.375089,"median":-1.049631,"eighty":-0.561512,"marketCap":120236928},{"date":"2023-04-21","current":-0.93131,"twenty":-4.350827,"median":-1.045347,"eighty":-0.564447,"marketCap":112424924},{"date":"2023-04-28","current":-0.796256,"twenty":-4.333642,"median":-1.038157,"eighty":-0.578468,"marketCap":96121612},{"date":"2023-05-05","current":-0.83137,"twenty":-4.313425,"median":-1.028722,"eighty":-0.598523,"marketCap":100360456},{"date":"2023-05-12","current":-0.880615,"twenty":-4.299272,"median":-1.023926,"eighty":-0.605036,"marketCap":106305152},{"date":"2023-05-19","current":-1.116393,"twenty":-4.286131,"median":-1.028722,"eighty":-0.610485,"marketCap":121217968},{"date":"2023-05-26","current":-0.929527,"twenty":-4.262881,"median":-1.029233,"eighty":-0.615332,"marketCap":100927993},{"date":"2023-06-02","current":-0.990896,"twenty":-4.248728,"median":-1.023926,"eighty":-0.617524,"marketCap":107591516},{"date":"2023-06-09","current":-0.889112,"twenty":-4.231543,"median":-1.019642,"eighty":-0.617565,"marketCap":96539820},{"date":"2023-06-16","current":-0.904081,"twenty":-4.19313,"median":-1.019043,"eighty":-0.617984,"marketCap":98165069},{"date":"2023-06-23","current":-0.814271,"twenty":-4.185043,"median":-1.018532,"eighty":-0.618997,"marketCap":88413572},{"date":"2023-06-30","current":-0.773857,"twenty":-4.071825,"median":-1.015357,"eighty":-0.620742,"marketCap":84025399},{"date":"2023-07-07","current":-0.724462,"twenty":-4.04352,"median":-1.008852,"eighty":-0.621558,"marketCap":78662075},{"date":"2023-07-14","current":-0.832233,"twenty":-4.001063,"median":-1.004647,"eighty":-0.623624,"marketCap":90363872},{"date":"2023-07-21","current":-0.769367,"twenty":-3.875713,"median":-0.998221,"eighty":-0.627024,"marketCap":83537824},{"date":"2023-07-28","current":-0.82668,"twenty":-3.765527,"median":-0.993459,"eighty":-0.629636,"marketCap":89760926},{"date":"2023-08-04","current":-0.868894,"twenty":-3.713973,"median":-0.985075,"eighty":-0.631445,"marketCap":94344463},{"date":"2023-08-11","current":-0.851305,"twenty":-3.672527,"median":-0.976564,"eighty":-0.632998,"marketCap":92434656},{"date":"2023-08-18","current":-0.898223,"twenty":-3.445079,"median":-0.976328,"eighty":-0.635471,"marketCap":88851359},{"date":"2023-08-25","current":-0.935024,"twenty":-3.25099,"median":-0.975262,"eighty":-0.637855,"marketCap":92491636},{"date":"2023-08-31","current":-0.935024,"twenty":-3.192359,"median":-0.973294,"eighty":-0.638939,"marketCap":92491636},{"date":"2023-09-08","current":-0.943887,"twenty":-3.141815,"median":-0.974334,"eighty":-0.640637,"marketCap":93368334},{"date":"2023-09-15","current":-0.966044,"twenty":-3.044538,"median":-0.974596,"eighty":-0.646397,"marketCap":95560079},{"date":"2023-09-22","current":-0.771062,"twenty":-2.921525,"median":-0.969731,"eighty":-0.650765,"marketCap":76272724},{"date":"2023-09-29","current":-0.904004,"twenty":-2.859779,"median":-0.965073,"eighty":-0.652187,"marketCap":89423193},{"date":"2023-10-06","current":-0.89071,"twenty":-2.744539,"median":-0.959532,"eighty":-0.652265,"marketCap":88108146},{"date":"2023-10-13","current":-0.864122,"twenty":-2.691973,"median":-0.95275,"eighty":-0.652875,"marketCap":85478053},{"date":"2023-10-20","current":-0.771062,"twenty":-2.629299,"median":-0.948916,"eighty":-0.654368,"marketCap":76272724},{"date":"2023-10-27","current":-0.691297,"twenty":-2.600994,"median":-0.945798,"eighty":-0.654976,"marketCap":68382442},{"date":"2023-11-03","current":-0.771062,"twenty":-2.545396,"median":-0.940916,"eighty":-0.655584,"marketCap":76272724},{"date":"2023-11-10","current":-0.697312,"twenty":-2.502939,"median":-0.938487,"eighty":-0.655584,"marketCap":65752348},{"date":"2023-11-17","current":-0.690685,"twenty":-2.474634,"median":-0.935024,"eighty":-0.65966,"marketCap":65127425},{"date":"2023-11-24","current":-0.728273,"twenty":-2.460482,"median":-0.935024,"eighty":-0.665095,"marketCap":68671775},{"date":"2023-12-01","current":-0.747067,"twenty":-2.441275,"median":-0.93131,"eighty":-0.669171,"marketCap":70443949},{"date":"2023-12-08","current":-0.977295,"twenty":-2.416003,"median":-0.930726,"eighty":-0.670259,"marketCap":92153091},{"date":"2023-12-15","current":-0.831641,"twenty":-2.396796,"median":-0.924102,"eighty":-0.671891,"marketCap":78418736},{"date":"2023-12-22","current":-0.784655,"twenty":-2.384666,"median":-0.920535,"eighty":-0.672068,"marketCap":73988299},{"date":"2023-12-29","current":-0.841038,"twenty":-2.375568,"median":-0.91698,"eighty":-0.672334,"marketCap":79304824},{"date":"2024-01-05","current":-0.9632,"twenty":-2.36647,"median":-0.920535,"eighty":-0.672474,"marketCap":90823960},{"date":"2024-01-12","current":-1.137046,"twenty":-2.342209,"median":-0.924102,"eighty":-0.674981,"marketCap":107216577},{"date":"2024-01-19","current":-1.021931,"twenty":-2.330078,"median":-0.930127,"eighty":-0.677698,"marketCap":96362006},{"date":"2024-01-26","current":-1.484737,"twenty":-2.317948,"median":-0.93131,"eighty":-0.680936,"marketCap":140001812},{"date":"2024-02-02","current":-1.743157,"twenty":-2.299752,"median":-0.935024,"eighty":-0.68368,"marketCap":164369216},{"date":"2024-02-09","current":-1.743157,"twenty":-2.293687,"median":-0.937011,"eighty":-0.685334,"marketCap":164369216},{"date":"2024-02-16","current":-2.626481,"twenty":-2.299752,"median":-0.940076,"eighty":-0.68714,"marketCap":247661433},{"date":"2024-02-23","current":-2.227106,"twenty":-2.305535,"median":-0.942402,"eighty":-0.688076,"marketCap":210002718},{"date":"2024-03-01","current":-2.988269,"twenty":-2.330078,"median":-0.94771,"eighty":-0.690807,"marketCap":281775799},{"date":"2024-03-08","current":-2.927188,"twenty":-2.389016,"median":-0.951922,"eighty":-0.691889,"marketCap":276016231},{"date":"2024-03-15","current":-2.227106,"twenty":-2.44633,"median":-0.953803,"eighty":-0.694552,"marketCap":210002718},{"date":"2024-03-22","current":-2.978041,"twenty":-2.463514,"median":-0.959532,"eighty":-0.695729,"marketCap":219749680},{"date":"2024-03-28","current":-3.308852,"twenty":-2.5272,"median":-0.963576,"eighty":-0.695729,"marketCap":244160175},{"date":"2024-04-05","current":-4.049404,"twenty":-2.643451,"median":-0.966044,"eighty":-0.696346,"marketCap":298805547},{"date":"2024-04-12","current":-4.151821,"twenty":-2.729849,"median":-0.970206,"eighty":-0.696927,"marketCap":306362886},{"date":"2024-04-19","current":-3.568833,"twenty":-2.927188,"median":-0.974596,"eighty":-0.696927,"marketCap":263344188},{"date":"2024-04-26","current":-3.387634,"twenty":-2.988269,"median":-0.976564,"eighty":-0.697312,"marketCap":249973512},{"date":"2024-05-03","current":-3.5187,"twenty":-3.030555,"median":-0.978065,"eighty":-0.699743,"marketCap":259644879},{"date":"2024-05-10","current":-3.598489,"twenty":-3.143409,"median":-0.983769,"eighty":-0.709023,"marketCap":265532518},{"date":"2024-05-17","current":-4.247436,"twenty":-3.277339,"median":-0.985368,"eighty":-0.709479,"marketCap":245514546},{"date":"2024-05-24","current":-3.890937,"twenty":-3.387634,"median":-0.992012,"eighty":-0.709599,"marketCap":224907809},{"date":"2024-05-31","current":-3.789857,"twenty":-3.432528,"median":-0.994328,"eighty":-0.710926,"marketCap":219065119},{"date":"2024-06-07","current":-3.606477,"twenty":-3.496972,"median":-0.998221,"eighty":-0.713593,"marketCap":208465194},{"date":"2024-06-14","current":-4.024176,"twenty":-3.528275,"median":-1.002505,"eighty":-0.715232,"marketCap":232609468},{"date":"2024-06-21","current":-3.443472,"twenty":-3.544174,"median":-1.006789,"eighty":-0.717202,"marketCap":199043038},{"date":"2024-06-28","current":-3.27028,"twenty":-3.546282,"median":-1.006789,"eighty":-0.718469,"marketCap":189031998},{"date":"2024-07-05","current":-2.934083,"twenty":-3.543661,"median":-1.012249,"eighty":-0.719102,"marketCap":169598802},{"date":"2024-07-12","current":-3.025773,"twenty":-3.528275,"median":-1.017751,"eighty":-0.722318,"marketCap":174898764},{"date":"2024-07-15","current":-3.209153,"twenty":-3.523487,"median":-1.018532,"eighty":-0.72339,"marketCap":185498689},{"date":"2024-08-02","current":-3.759294,"twenty":-3.542637,"median":-1.018787,"eighty":-0.724462,"marketCap":217298465},{"date":"2024-08-09","current":-3.54535,"twenty":-3.542637,"median":-1.01922,"eighty":-0.726748,"marketCap":204931886},{"date":"2024-08-16","current":-3.414893,"twenty":-3.535163,"median":-1.019642,"eighty":-0.728273,"marketCap":202171893},{"date":"2024-08-23","current":-3.633924,"twenty":-3.545198,"median":-1.023926,"eighty":-0.728273,"marketCap":215139186},{"date":"2024-08-30","current":-3.64388,"twenty":-3.568833,"median":-1.028147,"eighty":-0.728273,"marketCap":215728609},{"date":"2024-09-06","current":-3.484584,"twenty":-3.574764,"median":-1.029598,"eighty":-0.728273,"marketCap":206297850},{"date":"2024-09-13","current":-3.623968,"twenty":-3.60454,"median":-1.038157,"eighty":-0.730014,"marketCap":214549764},{"date":"2024-09-20","current":-3.663792,"twenty":-3.616003,"median":-1.045347,"eighty":-0.730587,"marketCap":216907454},{"date":"2024-09-27","current":-3.73382,"twenty":-3.623968,"median":-1.049631,"eighty":-0.732502,"marketCap":221053355},{"date":"2024-10-04","current":-3.52304,"twenty":-3.625864,"median":-1.057271,"eighty":-0.738629,"marketCap":208574536},{"date":"2024-10-11","current":-3.166721,"twenty":-3.623968,"median":-1.062484,"eighty":-0.745662,"marketCap":187479391},{"date":"2024-10-18","current":-3.242,"twenty":-3.616003,"median":-1.065075,"eighty":-0.747504,"marketCap":191936112},{"date":"2024-10-25","current":-3.763932,"twenty":-3.625864,"median":-1.066768,"eighty":-0.747613,"marketCap":222836043},{"date":"2024-10-31","current":-3.784006,"twenty":-3.637906,"median":-1.066768,"eighty":-0.748092,"marketCap":224024502},{"date":"2024-11-08","current":-3.954637,"twenty":-3.663792,"median":-1.071052,"eighty":-0.748411,"marketCap":234126403},{"date":"2024-11-15","current":-4.437354,"twenty":-3.685372,"median":-1.075336,"eighty":-0.749781,"marketCap":254513320},{"date":"2024-11-22","current":-2.177206,"twenty":-3.694157,"median":-1.080597,"eighty":-0.752917,"marketCap":124878030},{"date":"2024-11-29","current":-2.083898,"twenty":-3.693667,"median":-1.083246,"eighty":-0.755737,"marketCap":119526115},{"date":"2024-12-06","current":-1.7625,"twenty":-3.691387,"median":-1.086059,"eighty":-0.758203,"marketCap":101091739},{"date":"2024-12-13","current":-1.575883,"twenty":-3.686241,"median":-1.106883,"eighty":-0.759205,"marketCap":90387908},{"date":"2024-12-20","current":-1.596618,"twenty":-3.67968,"median":-1.116393,"eighty":-0.76056,"marketCap":91577222},{"date":"2024-12-27","current":-1.679559,"twenty":-3.673718,"median":-1.116393,"eighty":-0.762678,"marketCap":96334480},{"date":"2025-01-03","current":-1.752133,"twenty":-3.673597,"median":-1.123944,"eighty":-0.765861,"marketCap":100497082},{"date":"2025-01-10","current":-1.669192,"twenty":-3.665753,"median":-1.128264,"eighty":-0.766468,"marketCap":95739823},{"date":"2025-01-17","current":-1.524045,"twenty":-3.663792,"median":-1.133871,"eighty":-0.766629,"marketCap":87414621},{"date":"2025-01-24","current":-1.700295,"twenty":-3.658115,"median":-1.136181,"eighty":-0.768273,"marketCap":97523795},{"date":"2025-01-31","current":-1.679559,"twenty":-3.64806,"median":-1.148168,"eighty":-0.769367,"marketCap":96334480},{"date":"2025-02-07","current":-1.524045,"twenty":-3.64388,"median":-1.161021,"eighty":-0.770083,"marketCap":87414621},{"date":"2025-02-14","current":-1.347794,"twenty":-3.637906,"median":-1.165305,"eighty":-0.77056,"marketCap":77305447},{"date":"2025-02-21","current":-1.41,"twenty":-3.633924,"median":-1.174839,"eighty":-0.770761,"marketCap":80873391},{"date":"2025-02-28","current":-1.171544,"twenty":-3.633734,"median":-1.174839,"eighty":-0.771062,"marketCap":67196273},{"date":"2025-03-07","current":-1.223383,"twenty":-3.629657,"median":-1.181912,"eighty":-0.771062,"marketCap":70169560},{"date":"2025-03-14","current":-1.109339,"twenty":-3.623968,"median":-1.174839,"eighty":-0.771062,"marketCap":63628330},{"date":"2025-03-21","current":-0.892026,"twenty":-3.623745,"median":-1.171544,"eighty":-0.771314,"marketCap":68981264},{"date":"2025-03-28","current":-0.868132,"twenty":-3.619651,"median":-1.167447,"eighty":-0.772558,"marketCap":67133552},{"date":"2025-04-04","current":-0.745081,"twenty":-3.613757,"median":-1.161021,"eighty":-0.771314,"marketCap":57617833},{"date":"2025-04-11","current":-0.722621,"twenty":-3.613374,"median":-1.150809,"eighty":-0.771062,"marketCap":55880983},{"date":"2025-04-17","current":-0.743806,"twenty":-3.611995,"median":-1.149569,"eighty":-0.769606,"marketCap":57519288},{"date":"2025-04-25","current":-0.868132,"twenty":-3.605993,"median":-1.145145,"eighty":-0.769606,"marketCap":67133552},{"date":"2025-05-02","current":-0.876097,"twenty":-3.602943,"median":-1.135315,"eighty":-0.77056,"marketCap":67749456}],"updateTime":1746422071094}}}